Loading clinical trials...
Loading clinical trials...
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Conditions
Interventions
CM-AT
Locations
31
United States
Southwest Autism Research & Resource Center (S.A.R.R.C.)
Phoenix, Arizona, United States
University of Arizona, Pediatrics Multidisciplinary Research Unit
Tucson, Arizona, United States
Arkansas Children'S Hosp. Research Institute (A.C.H.R.I.)
Little Rock, Arkansas, United States
N.R.C. Research Institute
Orange, California, United States
M.I.N.D. Institute (Univ.of California, Davis)
Sacramento, California, United States
University of California (U.C.S.F.)
San Francisco, California, United States
Start Date
October 1, 2015
Primary Completion Date
January 1, 2028
Completion Date
January 1, 2028
Last Updated
March 18, 2026
NCT07439276
NCT07533331
NCT07421830
NCT05066178
NCT05501678
NCT00271622
Lead Sponsor
Curemark
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions